Disclosure UK
New benchmark reveals significant digital maturity gap across UK POM companies’ product-information estates
A new benchmark maps 100 UK prescription medicine companies across five maturity bands and finds a market at very different stages of digital development
Why pharma website projects stall long before compliance becomes the problem
Pharma teams often blame compliance when digital projects slow down. In reality, the bigger issue is usually weaker ownership, unclear review models and content structures that were never designed for...
Medical Misinformation and Sensationalism in the Age of Social Media
In today’s digital age, misinformation spreads faster than ever, often driven by sensational headlines and influencer content. These sources of misinformation often overshadow evidence-based content, creating confusion for both healthcare...
Why Pharma’s Digital PI Compliance Problem Needs a Cross-Functional Fix
In many pharma teams, the responsibility for keeping prescribing information (PI) up to date online falls into a grey area. > Regulatory signs it off. > Marketing publishes it. >...
Leveraging the ABPI QR Code Update: Enhancing Prescribing Information Through Best Practices
ABPI's recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility, providing clear instructions, linking directly, and keeping content current, companies can enhance accessibility, ensure...
Pi 360 – A Smarter, Automated Solution for Digital Prescribing Information (PI) & QR Code Compliance
Life sciences digital agency Genetic Digital has launched Pi 360, a cutting-edge web application designed to help pharmaceutical companies automate the creation, management and distribution of Prescribing Information (PI) while...
ABPI highlights importance of NHS-industry partnerships in improving patient outcomes
Hospitals engaging in industry partnerships were found to be up to 2.5 times more likely to follow NICE guidelines
2024 updates to the ABPI Code of Practice Clause 12
Iain Shield (Associate Director – Market Access, Mtech Access) has reviewed the changes to the ABPI Code of Practice, and highlights updates to prescribing information (Clause 12) and considerations around...
Championing people-powered communications in rare diseases: AMICULUM’s feature in The Guardian Rare Diseases Campaign 2024
By Ellie Thomas
UK government launches £400m investment programme to support clinical research
Up to 18 clinical trial hubs will be created to accelerate the development of new drugs
Life sciences leaders warn against ‘unworkable’ changes to UK medicines scheme
The scheme could impact UK life sciences and NHS patient access to medicines